Caberos, a medication with the active ingredient Cabergoline, is primarily used in the treatment of conditions associated with excess prolactin, such as prolactinomas and other hyperprolactinemic disorders. Its pharmacological action is derived from its ability to selectively activate dopamine D2 receptors, effectively inhibiting the secretion of prolactin from the pituitary gland.
Buy Caberos 0.125 mg for its pharmacological action at buy Caberos 0.125 mg.
Mechanism of Action
Cabergoline works through the following mechanisms:
- Dopamine Receptor Agonism: By stimulating the dopamine D2 receptors in the hypothalamus, Cabergoline reduces levels of prolactin.
- Inhibition of Prolactin Secretion: The activation of dopamine receptors in the pituitary gland directly inhibits prolactin release.
- Long Half-Life: Cabergoline has a long elimination half-life, allowing for once or twice weekly dosing, which enhances patient compliance.
Clinical Applications
Caberos is utilized in various clinical scenarios, including:
- Treatment of prolactin-secreting pituitary tumors (prolactinomas).
- Management of hyperprolactinemia.
- As part of treatment protocols for certain fertility issues related to elevated prolactin levels.
Conclusion
Caberos 0.125 mg offers a focused pharmacological approach for the management of hyperprolactinemia through its action as a selective dopamine D2 receptor agonist. By effectively lowering prolactin levels, it helps to alleviate symptoms and related complications associated with this endocrine disorder.
